Resistance training is any exercise that works muscle against a load: weights, bands, body weight, machines. Its effects on strength and muscle are among the most reproducible in exercise science and are not in question. This guide is about the harder claim, that it extends life, which rests on cohort studies and a handful of meta-analyses published since 2019.

The finding that surprised people is the shape of the curve. More is not better indefinitely. The lowest mortality in the pooled data sits at a modest weekly dose, and the studies that looked found the benefit shrinking at higher volumes.

Resistance training builds and preserves muscle, which with age is the difference between independence and frailty. It improves insulin sensitivity, since muscle is the largest site of glucose disposal, lowers blood pressure modestly, improves bone density and is one of the few interventions that reliably increases strength in old age. Each of those is a plausible route to lower mortality, and the cohort studies cannot say which matters most.

Why the benefit might plateau or reverse at high volumes is unknown. Candidates include reverse causation, since people who train many hours differ in other ways, and the possibility that very high training loads carry costs of their own. The curve is observed, not explained.

Any resistance training and mortality. A 2022 meta-analysis of 16 cohort studies found muscle-strengthening activity associated with 10 to 17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity. The associations were J-shaped, with the maximum reduction of 10 to 20% at about 30 to 60 minutes a week. A second 2022 meta-analysis of ten studies found any resistance training associated with 15% lower all-cause mortality, 19% lower cardiovascular mortality and 14% lower cancer mortality, with a maximum reduction of 27% at around 60 minutes a week and diminishing returns above.

A 2019 meta-analysis of 11 studies in 370,256 people found resistance training associated with 21% lower all-cause mortality alone and 40% lower combined with aerobic exercise, an additive effect.

The upper end. In the US Cancer Prevention Study-II cohort of 72,462 adults, under two hours a week of muscle-strengthening activity was associated with 10 to 12% lower mortality, and two hours or more with none. The authors could not explain the lack of association at higher volumes.

What this is and is not. Every one of these is an association between self-reported training and later death. The dose-response and the independence from aerobic activity make it harder to dismiss as healthy-person bias, and a randomized trial of resistance training and death will never be run.

Injury is the main risk, and it is mostly a matter of technique, progression and load; supervised beginners get hurt less. Acute cardiovascular events during heavy lifting are rare and concentrate in people with undiagnosed heart disease, which is the reason for medical clearance in older adults starting out. The high-volume end of the mortality curve is an observation, not a demonstrated harm, but it is a reason not to assume that more is better.

Not a product. Physical activity guidelines in the United States, the United Kingdom and the World Health Organization recommend muscle-strengthening activity on two or more days a week for adults, a target derived partly from the evidence here. This site links to those guidelines rather than restating them.